Protalix Biotherapeutics, Inc. (PLX)
2.475
+0.08
(+3.12%)
USD |
NYAM |
Aug 26, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics 1 Year Total Returns (Daily) : 50.00% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 50.00% |
| August 24, 2026 | 45.18% |
| August 21, 2026 | 50.63% |
| August 20, 2026 | 51.59% |
| August 19, 2026 | 53.59% |
| August 18, 2026 | 51.95% |
| August 17, 2026 | 54.73% |
| August 14, 2026 | 46.05% |
| August 13, 2026 | 46.58% |
| August 12, 2026 | 59.76% |
| August 11, 2026 | 50.93% |
| August 10, 2026 | 61.04% |
| August 07, 2026 | 62.91% |
| August 06, 2026 | 64.86% |
| August 05, 2026 | 71.83% |
| August 04, 2026 | 58.00% |
| August 03, 2026 | 60.00% |
| July 31, 2026 | 62.33% |
| July 30, 2026 | 52.35% |
| July 29, 2026 | 55.48% |
| July 28, 2026 | 55.33% |
| July 27, 2026 | 58.94% |
| July 24, 2026 | 52.90% |
| July 23, 2026 | 48.12% |
| July 22, 2026 | 50.00% |
| Date | Value |
|---|---|
| July 21, 2026 | 55.26% |
| July 20, 2026 | 66.21% |
| July 17, 2026 | 58.67% |
| July 16, 2026 | 61.54% |
| July 15, 2026 | 68.84% |
| July 14, 2026 | 62.68% |
| July 13, 2026 | 69.50% |
| July 10, 2026 | 64.86% |
| July 09, 2026 | 54.90% |
| July 08, 2026 | 60.81% |
| July 07, 2026 | 60.54% |
| July 06, 2026 | 49.35% |
| July 02, 2026 | 54.67% |
| July 01, 2026 | 55.41% |
| June 30, 2026 | 57.43% |
| June 29, 2026 | 52.60% |
| June 26, 2026 | 58.62% |
| June 25, 2026 | 57.45% |
| June 24, 2026 | 46.41% |
| June 23, 2026 | 60.74% |
| June 22, 2026 | 54.29% |
| June 18, 2026 | 58.57% |
| June 17, 2026 | 47.45% |
| June 16, 2026 | 44.06% |
| June 15, 2026 | 38.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Altimmune, Inc. | -5.60% |
| Taysha Gene Therapies, Inc. | 112.3% |
| Humacyte, Inc. | -53.25% |
| Agenus, Inc. | 90.43% |
| Amgen, Inc. | 57.54% |